Logo Image
News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPharmacy PerspectivesPodcastsShorts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians
Total Pharmacy

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Total Pharmacy
  • Allergy
  • Asthma
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
  • Wound Care Awareness
Spotlight -
ASHP Midyear |
FDA Updates|
Total Pharmacy
Advertisement

Justine Magalona, PharmD candidate

Advertisement

Articles by Justine Magalona, PharmD candidate

Review of FDA Approvals for Pediatric Obesity Management

ByCaitlyn Bradford, PharmD,Wade Tung, PharmD candidate,Justine Magalona, PharmD candidate,Natalie Catalan, PharmD candidate,Danielle M. Alm, PharmD, BCPS, BCPPS
October 3rd 2023

GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Drug Topics

    1

    Study Links Corticosteroid Use With Long COVID Symptoms

    2

    FDA Accepts Sandoz Applications for Generic Tirzepatide

    3

    FDA Panel to Evaluate 7 Popular Peptides for Compounding Substances List

    4

    Long COVID Risk Varies by Age, Epidemic Period

    5

    How GLP-1 Therapies Could Impact Bone Density, Muscle Loss

    • About
    • Advertise
    • Editorial
    • Editorial Board
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • AdvanCE
    • Total Pharmacy
    Drug Topics
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us